Wutah dodolan YoY sajrone 12 wulan kepungkur: Iovance Biotherapeutics (IOVA)

Logo perusahaan publik Iovance Corp (IOVA)

The 12-month year-over-year revenue growth rate illustrates the dynamics of Iovance Biotherapeutics (IOVA), where the 51.60 mark serves as a key metric. Growth is driven by the scaling of the clinic network to reduce costs. Stability of output is guaranteed by its own sterile manufacturing plant in Philadelphia, while a focus on innovation is maintained by outsourcing logistics and testing to external contractors.

Wutah pendapatan YoY sajrone 12 wulan kepungkur Iovance Biotherapeutics, Inc. (IOVA): kanggo periode 11.02.2024 - 18.11.2026

Iovance Biotherapeutics, Inc. (IOVA) - rincian metrik lan laporan keuangan

- rega pasar lan target rega analis:
Ringkesan analitik perusahaan:Iovance Biotherapeutics
Sampel barang iovance.com

This indicator tracks business expansion rates by comparing total revenue over the last 12 months with the same period last year to eliminate quarterly gaps. By analyzing the trajectory of the 12-month annual revenue change, an investor assesses the commercialization of TIL therapy by Iovance Biotherapeutics (IOVA), where a sharp increase in the metric confirms the successful market launch of a unique treatment method for advanced melanoma.

Pesaing Iovance Biotherapeutics (IOVA)

Wutah dodolan YoY (TTM) NantKwest IBRX|IMCR - Wutah dodolan YoY sajrone rolas wulan kepungkur|JANX (januxrx.com) - Wutah dodolan YoY sajrone 12 wulan kepungkur|Arcus Corp (RCUS) - Wutah dodolan YoY sajrone rolas wulan kepungkur|Wutah pendapatan taun lumaku Zymeworks Corp (ZYME)|Wutah pendapatan YoY sajrone 12 wulan kepungkur TNGX|IMTX - Tingkat wutah pendapatan YoY sajrone rolas wulan kepungkur|Wutah pendapatan YoY sajrone 12 wulan kepungkur XNCR (Xencor Corp)|Owah-owahan pendapatan YoY sajrone 12 wulan kepungkur CMPX|Wutah dodolan YoY (TTM) REPL (Replimune)|Dinamika pendapatan YoY sajrone rolas wulan kepungkur LYEL|innate-pharma.com - Wutah dodolan YoY (TTM)|Wutah pendapatan taun lumaku Pyxis Oncology|Compugen Limited (CGEN) - Wutah dodolan YoY sajrone rolas wulan kepungkur|IO Biotech, Inc. - Dinamika pendapatan YoY sajrone rolas wulan kepungkur|STRO (sutrobio.com) - Wutah dodolan YoY (TTM)|Wutah dodolan YoY (TTM) MiNK Therapeutics Inc.|Wutah dodolan YoY sajrone rolas wulan kepungkur werewolftx.com (HOWL)|IMMX: Wutah dodolan taun lumaku|alxoncology.com - Wutah pendapatan YoY sajrone 12 wulan kepungkur|CUE - Wutah pendapatan YoY sajrone 12 wulan kepungkur|PDSB - Wutah dodolan YoY sajrone rolas wulan kepungkur|Wutah pendapatan taunan sajrone rolas wulan kepungkur Sonnet BioTherapeutics Holdings SONN|MAIA: Wutah dodolan YoY (TTM)|LIMN - Wutah pendapatan taunan sajrone rolas wulan kepungkur|Wutah pendapatan YoY sajrone 12 wulan kepungkur LVTX|Wutah dodolan YoY sajrone 12 wulan kepungkur NXTC (NextCure)|Wutah dodolan YoY sajrone rolas wulan kepungkur leaptx.com (LPTX)|INTS - Wutah pendapatan taun lumaku|Wutah dodolan YoY (TTM) SNSE (Sensei Biotherapeutics, Inc.)|Wutah pendapatan taunan sajrone rolas wulan kepungkur Theriva Biologics, Inc. (TOVX)|GRTS: Wutah pendapatan YoY sajrone 12 wulan kepungkur|Wutah pendapatan taunan sajrone rolas wulan kepungkur kinetabio.com KA|NEXI (neximmune.com) - Wutah pendapatan YoY sajrone 12 wulan kepungkur|Wutah pendapatan taun lumaku Turnstone Biologics Corporation (TSBX)|Wutah pendapatan YoY sajrone 12 wulan kepungkur VCNX|HARP: Dinamika pendapatan YoY sajrone rolas wulan kepungkur